期刊文献+

两种检测系统测定血清半胱氨酸蛋白酶抑制剂C的偏差评估 被引量:7

Evaluation on the bias of two detection systems for serum cystatin C
下载PDF
导出
摘要 目的对液相透射比浊检测系统和颗粒增强散射比浊检测系统测定半胱氨酸蛋白酶抑制剂C(CysC)结果偏差进行方法学比较及偏差评估。方法按照美国临床实验室标准化委员会(NCCLS)EP9-A2文件,以40例血清标本分别在罗氏MODULAR P800全自动生化分析仪和西门子BN-II特定蛋白分析仪上进行双份重复测定。将测定数据结果进行离群点检查,线性回归分析,计算预期偏差及可信区间(CI)。结果 2种检测系统Cys C测定结果的相关回归方程为Y=1.216X-0.139,r2=0.978。浓度为0.53、0.95 mg/L时,允许误差在预期偏差95%CI范围内;Cys C浓度为7.85 mg/L时,允许误差<预期偏差95%CI下限。结论 2种检测系统的测定结果呈线性相关。在低浓度时,预计偏差可以接受。在高浓度时,测定结果不一致,预期偏差不可以接受。 Objective To compare methodologically and evaluate the bias of turbidimetric assay and particle- enhanced nephelometric assay for serum cystatin C (Cys C ). Methods According to the National Committee for Clinical Laboratory Standards (NCCLS) EPg-A2 document, 40 serum samples were determined in duplicate measurement by Roche MODULAR PS00 automatic biochemical analyzer and Siemens BN-Ⅱ specific protein analyzer, respectively. The data were used to check outliers, linear regression was analyzed, and the predictive bias and confidence interval(CI) were calculated. Results The linear regression equation was Y = 1. 216X -0. 139 ,r2 = 0. 978. When the Cys C concentrations were 0.53 mg/L and 0.95 mg/L, the acceptable biases were in the range of 95% CI of predictive bias. However, when the Cys C concentration was 7.85 mg/L, the acceptable bias was 〈 the low limit of 95% CI of predictive bias. Conclusions The results of the 2 detection systems have linear correlation. The predictive bias of measured results between the 2 detection systems is acceptable except the high concentration.
作者 戴悦 吴文清
出处 《检验医学》 CAS 2013年第5期408-411,共4页 Laboratory Medicine
关键词 半胱氨酸蛋白酶抑制剂C 液相透射比浊系统 颗粒增强散射比浊系统 偏差 Cystatin C Turbidimetric assay Particle-enhanced nephelometric assay Bias
  • 相关文献

参考文献12

二级参考文献63

共引文献71

同被引文献52

  • 1贺国平,金伯平,王晓明.1438例肺炎支原体肺炎患儿临床及肺外并发症分析[J].临床儿科杂志,2005,23(10):723-723. 被引量:59
  • 2李海霞,张春丽,徐国宾,王学晶,李淑葵,李志艳,张旭初,夏铁安.健康人群血清半胱氨酸蛋白酶抑制剂C与肌酐分布及其评价慢性肾脏病患者肾小球滤过功能的比较研究[J].中华检验医学杂志,2006,29(11):970-974. 被引量:179
  • 3White C,Akbari A,Hussain N,et al. Estimating glomerularfiltration rate in kidney transplantation : a comparison betweenserum creatinine and cystatin C-based methods [J]. J Am SocNephrol, 2005,16: 3763-3770.
  • 4Perkins BA, Nelson RG,Ostrander BE, et al. Detection of renalfunction decline in patients with diabetes and normal or elevatedGFR by serial measurements of serum cystatin C concentration :results of a 4-year follow-up study[J]. J Am Soc Nephrol, 2005,16: 1404-1412.
  • 5CLSI. User Verification of Performance for Precision andTrueness, Approved Guideline-Second Edition. CLSI documentEP15-A2. Wayne, PA: CLSI, 2005.
  • 6CLSI. Method comparison and bias estimation using patientsamples,Approved Guideline-Second Edition. CLSI documentEP9-A2. Wayne, PA: CLSI, 2002.
  • 7Ricos C, Alvarez V,Cava F, et al. Current databases onbiological variation: pros,cons and progress [J]. Scand J ClinLab Invest, 1999, 59: 491-500.
  • 8Grubb A, Blirup-Jensen S, LindstrCm V,et al. First certifiedreference material for cystatin C in human serum ERM-DA471/IFCC[J]. Clin Chem Lab Med, 2010,48: 1619-1621.
  • 9Voskoboev NV, Larson TS, Rule AD, et al. Analytic and clinicalvalidation of a standardized cystatin C particle enhancedturbidimetric assay ( PETIA) to estimate glomerular filtration rate[J]. Clin Chem Lab Med, 2012,50: 1591-1596.
  • 10BaxmannAC,AhmedMS,MarquesNC,etal.Influenceofmusclemassandphysicalactivityonserum andurinarycreatinineandserum cystatinC[J].ClinJAmSocNephrol,2008,3(2):348-354.

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部